Table 2. Significantly altered KEGG pathways in mammary gland upon 96h of 80kVp/0.1 Gy in comparison to the corresponding un-treated controls.
Pathways | Pathway Significance, % (total number of genes) |
---|---|
Antigen processing and presentation | + 93.8% (16) |
B cell receptor signaling | + 100% (13) |
Cell adhesion molecules (CAM) | + N/S (20) |
Chemokine signaling | + 100% (14) |
Citrate cycle (TCA) | − 100% (8) |
Cytosolic DNA-sensing pathway | + 100% (6) |
ECM-receptor interaction | − 88.9% (9) |
Fatty acid metabolism | − 100% (6) |
Fc epsilon RI signaling | + 100% (10) |
Fc gamma R-mediated phagocytosis | + 100% (11) |
Glutathione metabolism | − 85.7% (7) |
Graft-vs-host disease | + 100% (7) |
Hematopoietic cell lineage | + N/S (9) |
Intestinal immune network for IgA production | + 100% (6) |
Leukocyte transendothelial migration | + 89.5% (19) |
Lysosome | + N/S (13) |
Natural killer cell mediated cytotoxicity | + 100% (18) |
PPAR signaling | − 100% (10) |
Primary immunodeficiency | + 100% (8) |
Pyruvate metabolism | − 100% (7) |
T cell receptor signaling | + 100% (15) |
Tryptophan metabolism | − 83.3 % (6) |